Predicting outcomes in malignant ovarian germ cell tumors using the modified International Germ Cell Cancer Collaborative Group classification system

被引:0
|
作者
Zhang, Xinyue [1 ,2 ]
Yang, Jie [1 ,2 ]
Xiang, Yang [1 ]
Wu, Ming [1 ]
Cao, Dongyan [1 ]
Wang, Jinhui [1 ]
Yang, Jiaxin [1 ,2 ]
机构
[1] Peking Union Med Coll Hosp, Obstet & Gynecol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
Ovarian Neoplasms; Ovarian Diseases; PROGNOSTIC-FACTORS; CHEMOTHERAPY; MANAGEMENT; SURVIVAL; COHORT;
D O I
10.1136/ijgc-2024-005489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The aim of our study was to evaluate the feasibility of the modified International Germ Cell Cancer Collaborative Group risk classification system in Chinese female patients with malignant ovarian germ cell tumors and to identify predictive factors to enhance the risk classification system. Methods In this retrospective cohort analysis, patients with malignant ovarian germ cell tumors who received surgery with/without chemotherapy were included. These patients had been followed-up by Peking Union Medical College Hospital between 2011 to 2020. Patients without complete medical records or no follow-up information were excluded. Results The study enrolled a total of 271 patients. The risk model classified 106 (39.1%) patients as good-, 84 (31%) as intermediate-, and 81 (29.9%) as poor-risk. With a median follow-up time of 34 months (range 2-147), 48 (17.7%) recurrence and 16 (5.9%) deaths were observed. The risk classification significantly correlated with 3 year disease-free survival and overall survival (log rank p<0.001 and p=0.003, respectively). The survival outcomes of disease-free survival and overall survival were not statistically different among risk groups in patients who received neoadjuvant chemotherapy (log rank p=0.77 and 0.41, respectively). Univariate and multivariable analysis showed that tumor stage (p=0.033, hazard ratio (HR) 2.05, 95% confidence interval (CI) 1.06 to 3.96) was significantly associated with relapse or progression of disease. Patients over age 40 years exhibited a poor prognosis. Conclusion The modified International Germ Cell Cancer Collaborative Group risk classification system was efficacious in patients with malignant ovarian germ cell tumors and was significantly associated with disease-free survival and overall survival. Risk assessment after neoadjuvant chemotherapy may be more predictive than stratification at initial diagnosis. Age and tumor stage were definitive prognostic factors for germ cell tumors, which may need to be incorporated in the stratification system.
引用
收藏
页码:1745 / 1752
页数:8
相关论文
共 50 条
  • [41] Significance of the Complete Surgical Staging of Stage I Malignant Ovarian Germ Cell Tumors
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (09) : 2982 - 2987
  • [42] Clinical outcome of lymphadenectomy in malignant ovarian germ cell tumors: a systematic review and meta-analysis
    Han, Ling
    Chen, Yali
    Liu, Yana
    Zheng, Ai
    Chen, Hengxi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (09): : 4458 - 4467
  • [43] MALIGNANT GERM-CELL TUMORS IN CHILDHOOD
    NAIR, R
    PAI, SK
    SAIKIA, TK
    NAIR, CN
    KURKURE, PA
    GOPAL, R
    SAMPAT, MS
    ADVANI, SH
    JOURNAL OF SURGICAL ONCOLOGY, 1994, 56 (03) : 186 - 190
  • [44] Malignant ovarian germ cell tumors: Presentation, survival and second cancer in a population based Norwegian cohort (1953-2009)
    Solheim, O.
    Kaern, J.
    Trope, C. G.
    Rokkones, E.
    Dahl, A. A.
    Nesland, J. M.
    Fossa, S. D.
    GYNECOLOGIC ONCOLOGY, 2013, 131 (02) : 330 - 335
  • [45] Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors
    Brown, Jubilee
    Friedlander, Michael
    Backes, Floor J.
    Harter, Philipp
    O'Connor, Dennis M.
    Rouge, Thibault de la Motte
    Lorusso, Domenica
    Maenpaa, Johanne
    Kim, Jae-Weon
    Tenney, Meghan E.
    Seckl, Michael J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : S48 - S54
  • [46] Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study
    Tamauchi, Satoshi
    Kajiyama, Hiroaki
    Yoshihara, Masato
    Ikeda, Yoshiki
    Yoshikawa, Nobuhisa
    Nishino, Kimihiro
    Utsumi, Fumi
    Niimi, Kaoru
    Suzuki, Shiro
    Kikkawa, Fumitaka
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 219 (04) : 385.e1 - 385.e7
  • [47] Minimally Invasive Staging of Apparent Stage I Malignant Ovarian Germ Cell Tumors: Prevalence and Outcomes
    Nasioudis, Dimitrios
    Minis, Evelyn
    Chapman-Davis, Eloise
    Frey, Melissa K.
    Caputo, Thomas A.
    Witkin, Steven S.
    Holcomb, Kevin
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2019, 26 (03) : 471 - 476
  • [48] Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery
    Vasta, Francesca Maria
    Dellino, Miriam
    Bergamini, Alice
    Gargano, Giulio
    Paradiso, Angelo
    Loizzi, Vera
    Bocciolone, Luca
    Silvestris, Erica
    Petrone, Micaela
    Cormio, Gennaro
    Mangili, Giorgia
    BIOMEDICINES, 2020, 8 (12) : 1 - 13
  • [49] Management of bilateral malignant ovarian germ cell tumors: Experience of a single institute
    Zhao, Ting
    Liu, Yan
    Jiang, Hongyuan
    Zhang, Hao
    Lu, Yuan
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (02) : 383 - 387
  • [50] Malignant Ovarian Germ Cell Tumors: In Prepubertal Adolescents from Kumaon Region
    Jain G.
    Pandey J.
    Indian Journal of Gynecologic Oncology, 2017, 15 (3)